Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients (Q41875844)

13 October 2017

Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients (English)

1 reference

13 October 2017

Fogari R

1

1 reference

13 October 2017

Zoppi A

2

1 reference

13 October 2017

Malamani GD

3

1 reference

13 October 2017

Marasi G

4

1 reference

13 October 2017

Vanasia A

5

1 reference

13 October 2017

Villa G

6

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

British Journal of Clinical Pharmacology

13 October 2017

1 reference

13 October 2017

39

1 reference

13 October 2017

5

1 reference

13 October 2017

471-476

1 reference

Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Plasma fibrinogen--a major coronary risk factor

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Captopril and hydrochlorothiazide: rationale for their combination

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Effects of diuretic drugs on the lipid profile

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Antihypertensive treatment and serum lipoproteins

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Improvement of silent myocardial ischaemia and reduction of plasma fibrinogen during nisoldipine therapy in occult coronary arterial disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Cardiovascular risk factors and their interactions in hypertensives

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Management of multiple risk factors for coronary heart disease in patients with hypertension

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Drugs affecting plasma fibrinogen levels

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Lowering the plasma fibrinogen concentration with drugs

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

Relation between extent of coronary artery disease and blood viscosity.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365052

[Rapid physiological coagulation method in determination of fibrinogen]

14 June 2018

1 reference

12 December 2020

[Enzymatic determination of total cholesterol in serum (author's transl)]

1 reference

12 December 2020

Rheological aspects of cerebrovascular disease

1 reference

12 December 2020

Essential hypertension. The behaviour of the haemorheological determinants and their trends during beta-blocker treatment

1 reference

12 December 2020

Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in angina pectoris before and after propranolol therapy

1 reference

12 December 2020

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

12 December 2020

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

12 December 2020

Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study

1 reference

12 December 2020

Analysis of risk factors for stroke in a cohort of men born in 1913

1 reference

12 December 2020

Hypertension and other risk factors in coronary heart disease

1 reference

12 December 2020

Smoking and plasma fibrinogen

1 reference

12 December 2020

Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension

1 reference

12 December 2020

Importance of coronary heart disease risk factors in the management of hypertension. An overview

1 reference

12 December 2020

Diabetic hypertension--the importance of fibrinogen and blood viscosity

1 reference

12 December 2020

Effect of fibrinogen concentration on the velocity of platelet aggregation

1 reference

12 December 2020

10.1111/J.1365-2125.1995.TB04482.X

Identifiers

DOI

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

7669481

1 reference